The challenge as I see it, is that CGB doesn't sell much and doesn't seem to have any products (drugs) in development phase (at least).
Whereas, many medicinal marijuana companies have products in clinical trials and many with drugs hitting the ground.
As a long term holder, I got drawn into the conversation about the 'big stash of seeds' we apparently had and the trials in Israel or collaboration with Canntab in Canada... where is all that? Where has it gone? etc etc
My point, these guys will talk the next thing up like a 3rd hand car with a shiny paint job... get excited cautiously.
Sadly they don't seem to under what makes money - sales of great products.
- Forums
- ASX - By Stock
- CGB
- Will we all be rich tomorrow?
Will we all be rich tomorrow?, page-9
-
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online